Democratizing exoskeleton technology worldwide

ABLE Human Motion

ABLE Human Motion is a medical device company that develops cutting-edge exoskeleton technology to improve the mobility, health, and quality of life of people with disabilities.

Headquartered in Barcelona, our team designs, manufactures, sells, and maintains our products for customers across the European Union.

Vision

To build a world where everyone has the freedom to move independently, regardless of their physical limitations.

Mission

To create the world’s most usable and accessible robotic exoskeletons. To promote the widespread adoption of this life-changing technology for people with disabilities, improving their rehabilitation, mobility, quality of life, and health.

Our Values

Inclusiveness

Being different makes us unique

We focus on people. We respect and value diversity and are committed to equality. We believe these are the values that drive innovation. The final goal of our inventions is to promote a healthy lifestyle, improve rehabilitation and empower engagement in the community, in social activities and events with family and friends. Therefore, we celebrate joining multiple perspectives to create enriching environments and experiences. And doing so while having fun.

High-quality

Building safe and high-quality products

We’re committed to building high-quality, safe and top performance products that provide benefits for clinical customers and patients, achieving high levels of satisfaction. Our organisation has obtained the ISO-13485 quality system certification, ensuring that our exoskeletons are manufactured under the highest standards applicable to medical devices. We’re proud members of the International Industry Society in Advanced Rehabilitation Technology (IISART).

Innovation

Cutting-edge technology backed by research

Research is a fundamental part of our innovation process: to explore disruptive ideas, build first proofs of concept and generate clinical evidence. Our partnerships with the Research Centre for Biomedical Engineering of UPC and renowned neurorehabilitation institutions such as Institut Guttmann and Heidelberg University Hospital make it possible to go beyond what seems possible, benefiting from state-of-the-art equipment and best clinical practices.

User-Centric

Continuous improvement from user’s feedback

Co-creation is crucial to developing meaningful rehabilitation technology. We engage with clinical professionals and people with disabilities as part of our team, integrating their feedback into the design to create products that optimally solve their needs. We love listening to customers towards the continuous improvement of our products and services. We strive for excellence, every detail and every opinion matters.

Our Facilities

We are hosted in Parc Tecnològic Barcelona Activa, a 10,000 m2 Business Park for tech companies located in Barcelona. Our facilities include:

Fully equipped R&D workshop to build mechatronic prototypes using multiple fungible materials.
Production Area with high-tech equipment and quality control systems to assemble and repair our exoskeletons.
Laboratory equipment to capture objective data during testing sessions of the exoskeleton.
A new office space with multiple meeting rooms, and coffee break, lunch, chill and outdoor areas.

Our history

ABLE Human Motion was founded in October 2018 by 2 engineering classmates (Alfons Carnicero and Alex Garcia) and a professor of mechanical engineering (Josep M. Font) that aimed to help people with mobility impairments through game-changing technology. The company is a spin-off of Universitat Politècnica de Catalunya (UPC), created after several years of research and development by the Biomechanical Engineering Lab. Here’s a summary of our story:

2024

CE marking as a medical device of ABLE Exoskeleton, our first commercial exoskeleton for clinical use.

2023

ABLE Exoskeleton tested by +200 individuals with spinal cord injury, that walked +400,000 steps.

2022

Clinical trial on safety and performance of the ABLE Exoskeleton (hip-knee powered) conducted at Asepeyo Hospital.

2021

Clinical trial on safety and performance with our knee-powered exoskeleton conducted at Institut Guttmann and Heidelberg University Hospital.

2020

Prototype of the knee-powered exoskeleton with passive hips manufactured and ready to be used with patients.

2019

Event to present the project and close a pre-seed investment round of 704 k€ with Business Angels, early-stage funds and family and friends.

2018

Foundation of ABLE Human Motion by 2 engineering classmates (Alfons Carnicero and Alex Garcia) and Josep M. Font, based on the results of the research project (tested with 1 SCI individual).

2015

The UPC professor Josep M. Font starts a research project to build low-cost powered orthoses collaborating with the Spanish universities of Coruña (UDC) and Extremadura (UEX).

1 / 8